两全其美:一种用于术前和术中最佳识别前哨淋巴结的混合方法
这项前瞻性试验在495例不同恶性肿瘤患者中评估了混合示踪剂ICG-99mTc-纳米胶体用于前哨淋巴结活检的价值。术前SPECT/CT识别1327个热点,术中基于γ探测(>98%)和荧光引导(>95%)识别1643枚前哨淋巴结;在300例使用蓝染料患者中荧光检测优于蓝染料目视检测(22-78%)。结论认为该混合示踪剂使前哨淋巴结活检更准确且不依赖蓝染料,并适用于不同恶性肿瘤和解剖部位。
要点
- 荧光引导前哨淋巴结检测优于蓝染料目视检测(22-78%)。
- 术中γ探测识别率>98%,荧光引导识别率>95%。
- 未发现与混合示踪剂或荧光引导相关的不良反应。
核心结论
- 使用ICG-99mTc-纳米胶体可使前哨淋巴结活检更准确且不依赖蓝染料的使用。
- 该操作已发展为适用于不同恶性肿瘤和解剖部位的通用方法。
研究设计与样本
- 前瞻性试验,纳入495例不同恶性肿瘤患者,共501例次操作。
- 肿瘤类型包括皮肤恶性肿瘤、口腔癌、阴茎癌、前列腺癌和外阴癌。
- 患者自身对照,将混合引导与传统放射引导及蓝染料使用(n=300)进行比较。
主要发现
- 术前501次SPECT/CT扫描共识别1327个前哨淋巴结相关热点。
- 术中基于γ探测(>98%)和荧光引导(>95%)联合识别共1643枚前哨淋巴结。
- 在300例使用蓝染料患者中,荧光前哨淋巴结检测优于蓝染料目视检测(22-78%)。
- 未发现与混合示踪剂或荧光引导操作相关的不良反应,结局指标未受到负面影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Hybrid image-guided surgery technologies such as combined radio- and fluorescence-guidance are increasingly gaining interest, but their added value still needs to be proven. In order to evaluate if and how fluorescence-guidance can help realize improvements beyond the current state-of-the-art in sentinel node (SN) biopsy procedures, use of the hybrid tracer indocyanine green (ICG)-99mTc-nancolloid was evaluated in a large cohort of patients. PATIENTS AND METHODS: A prospective trial was conducted (n = 501 procedures) in a heterogeneous cohort of 495 patients with different malignancies (skin malignancies, oral cavity cancer, penile cancer, prostate cancer and vulva cancer). After injection of ICG-99mTc-nanocolloid, SNs were preoperatively identified based on lymphoscintigraphy and SPECT/CT. Intraoperatively, SNs were pursued via gamma tracing, visual identification (blue dye) and/or near-infrared fluorescence imaging during either open surgical procedures (head and neck, penile, vulvar cancer and melanoma) or robot assisted laparoscopic surgery (prostate cancer). As the patients acted as their own control, use of hybrid guidance could be compared to conventional radioguidance and the use of blue dye (n = 300). This was based on reported surgical complications, overall survival, LN recurrence free survival, and false negative rates (FNR). RESULTS: A total of 1,327 SN-related hotspots were identified on 501 preoperative SPECT/CT scans. Intraoperatively, a total number of 1,643 SNs were identified based on the combination of gamma-tracing (>98%) and fluorescence-guidance (>95%). In patients wherein blue dye was used (n = 300) fluorescence-based SN detection was superior over visual blue dye-based detection (22-78%). No adverse effects related to the use of the hybrid tracer or the fluorescence-guidance procedure were found and outcome values were not negatively influenced. CONCLUSION: With ICG-99mTc-nanocolloid, the SN biopsy procedure has become more accurate and independent of the use of blue dye. With that, the procedure has evolved to be universal for different malignancies and anatomical locations.
引用
- KleinJan GH, van Werkhoven E, van den Berg NS, et al. The best of both worlds: a hybrid approach for optimal pre- and intraoperative identification of sentinel lymph nodes. Eur J Nucl Med Mol Imaging. 2018. PMID: 29696442. doi:10.1007/s00259-018-4028-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。